Bleomycin: a clinical evaluation of the agent on its own or in combination with mitomycin C.
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003875:Drug Eruptions / Q000209:etiology; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007275:Injections, Intravenous; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008297:Male; D008937:Mitomycins / Q000008:administration & dosage / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy*; D010859:Pigmentation Disorders / Q000139:chemically induced; D012004:Rectal Neoplasms / Q000188:drug therapy; D012075:Remission, Spontaneous
D000903:Antibiotics, Antineoplastic; D008937:Mitomycins; D001761:Bleomycin